Fingerprint
Dive into the research topics of 'Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma
Sikander Ailawadhi, Jeff Miecznikowski, Dan P. Gaile, Dongliang Wang, Taimur Sher, George Mulligan, Barb Bryant, Gregory E. Wilding, Terry Mashtare, Leighton Stein, Aisha Masood, Rachel Neuwirth, Kelvin P. Lee, Asher Chanan-Khan
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations